Literature DB >> 2249125

Treatment of infants with neurogenic bladder dysfunction using anticholinergic drugs and intermittent catheterisation.

L S Baskin1, B A Kogan, F Benard.   

Abstract

The use of anticholinergic drugs in infants with neurogenic dysfunction has not been well documented. In this study, 35 neonates at risk of upper urinary tract damage from neurogenic dysfunction were treated from infancy with anticholinergics, in combination with clean intermittent catheterisation. None of the patients showed upper urinary tract deterioration with follow-up ranging from 6 to 72 months, although 2 required vesicostomy--1 due to difficulty with catheterisation and 1 due to possible anticholinergic side effects. Only 2 (6%) have had clinical pyelonephritis. Twenty-five (76%) are virtually dry between catheterisation. We conclude that anticholinergics are safe and effective, even in the neonatal period, when used in combination with clean intermittent catheterisation for the treatment of neonates with neurogenic bladder dysfunction.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2249125     DOI: 10.1111/j.1464-410x.1990.tb15004.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  7 in total

1.  Systematic review of therapy for neurogenic detrusor overactivity.

Authors:  Clare J Fowler
Journal:  Can Urol Assoc J       Date:  2011-10       Impact factor: 1.862

2.  Treatment outcomes according to neuropathic bladder sphincter dysfunction type after treatment of oxybutynin chloride in children with myelodysplasia.

Authors:  Minki Baek; Jung Yoon Kang; Jeongyun Jeong; Dae Kyung Kim; Kwang Myung Kim
Journal:  Int Urol Nephrol       Date:  2013-03-31       Impact factor: 2.370

Review 3.  Early Vs. Expectant Management of Spina Bifida Patients-Are We All Talking About a Risk Stratified Approach?

Authors:  Angelena B Edwards; Micah Jacobs
Journal:  Curr Urol Rep       Date:  2019-11-16       Impact factor: 3.092

Review 4.  [Neurogenic bladder function disorders in patients with meningomyelocele: S2k guidelines on diagnostics and therapy].

Authors:  R Stein; C Assion; R Beetz; M Bürst; R Cremer; A Ermert; M Goepel; E Kuwertz-Bröking; B Ludwikowski; T Michael; J Pannek; H Peters; D Rohrmann; I Rübben; A Schröder; R Trollmann; J W Thüroff; W Wagner
Journal:  Urologe A       Date:  2015-02       Impact factor: 0.639

Review 5.  [Urological problems in patients with meningomyelocele. Diagnostic studies and management].

Authors:  R Stein; A Schröder; R Beetz; A Ermert; D Filipas; M Fisch; M Goepel; I Körner; B Schönberger; C Sparwasser; M Stöhrer; J W Thüroff
Journal:  Urologe A       Date:  2007-12       Impact factor: 0.639

Review 6.  The neurogenic bladder: medical treatment.

Authors:  Carla Verpoorten; Gunnar M Buyse
Journal:  Pediatr Nephrol       Date:  2007-12-19       Impact factor: 3.714

Review 7.  Preventing kidney injury in children with neurogenic bladder dysfunction.

Authors:  Faezeh Javadi Larijani; Mastaneh Moghtaderi; Nilofar Hajizadeh; Farahnak Assadi
Journal:  Int J Prev Med       Date:  2013-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.